Inhibition of soluble tumour necrosis factor is therapeutic in experimental autoimmune encephalomyelitis and promotes axon preservation and remyelination

Author： Brambilla Roberta  

Publisher： Oxford University Press

ISSN： 1460-2156

Source： Brain, Vol.134, Iss.9, 2011-09, pp. : 2736-2754

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Transmembrane tumour necrosis factor is neuroprotective and regulates experimental autoimmune encephalomyelitis via neuronal nuclear factor-B

By Taoufik Era  

Brain, Vol. 134, Iss. 9, 2011-09 ,pp. : 2722-2735

Oxford University Press

Access to resources Recommend Favorite

Suppression of Experimental Autoimmune Encephalomyelitis by Tyrphostin AG-556

By Brenner T.   Poradosu E.   Soffer D.   Sicsic C.   Gazit A.   Levitzki A.  

Experimental Neurology, Vol. 154, Iss. 2, 1998-12 ,pp. : 489-498

Elsevier

Access to resources Recommend Favorite

Identification of endothelin 2 as an inflammatory factor that promotes central nervous system remyelination

By Yuen Tracy J.  

Brain, Vol. 136, Iss. 4, 2013-04 ,pp. : 1035-1047

Oxford University Press

Access to resources Recommend Favorite

Inhibition of matrix metalloproteinases and tumour necrosis factor α converting enzyme as adjuvant therapy in pneumococcal meningitis

By Leib S.L.  

Brain, Vol. 124, Iss. 9, 2001-09 ,pp. : 1734-1742

Oxford University Press

Access to resources Recommend Favorite

Neuroprotection in a rabbit model of intraventricular haemorrhage by cyclooxygenase-2, prostanoid receptor-1 or tumour necrosis factor-alpha inhibition

By Vinukonda Govindaiah  

Brain, Vol. 133, Iss. 8, 2010-08 ,pp. : 2264-2280

Oxford University Press

Access to resources Recommend Favorite